366 related articles for article (PubMed ID: 30010033)
1. DNMT1 controls LncRNA H19/ERK signal pathway in hepatic stellate cell activation and fibrosis.
Yang JJ; She Q; Yang Y; Tao H; Li J
Toxicol Lett; 2018 Oct; 295():325-334. PubMed ID: 30010033
[TBL] [Abstract][Full Text] [Related]
2. MeCP2 silencing of LncRNA H19 controls hepatic stellate cell proliferation by targeting IGF1R.
Yang JJ; Liu LP; Tao H; Hu W; Shi P; Deng ZY; Li J
Toxicology; 2016 Jun; 359-360():39-46. PubMed ID: 27350269
[TBL] [Abstract][Full Text] [Related]
3. Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion.
Wu Y; Liu X; Zhou Q; Huang C; Meng X; Xu F; Li J
Toxicol Appl Pharmacol; 2015 Dec; 289(2):163-76. PubMed ID: 26435214
[TBL] [Abstract][Full Text] [Related]
4. A lncRNA Gpr137b-ps/miR-200a-3p/CXCL14 axis modulates hepatic stellate cell (HSC) activation.
Liao J; Zhang Z; Yuan Q; Liu Q; Kuang J; Fang Y; Hu X
Toxicol Lett; 2021 Jan; 336():21-31. PubMed ID: 33069761
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of DNMT1 leads to hypermethylation of H19 promoter and inhibition of Erk signaling pathway in disuse osteoporosis.
Li B; Zhao J; Ma JX; Li GM; Zhang Y; Xing GS; Liu J; Ma XL
Bone; 2018 Jun; 111():82-91. PubMed ID: 29555308
[TBL] [Abstract][Full Text] [Related]
6. HIF-1α-upregulated lncRNA-H19 regulates lipid droplet metabolism through the AMPKα pathway in hepatic stellate cells.
Wang Z; Yang X; Kai J; Wang F; Wang Z; Shao J; Tan S; Chen A; Zhang F; Wang S; Zhang Z; Zheng S
Life Sci; 2020 Aug; 255():117818. PubMed ID: 32445757
[TBL] [Abstract][Full Text] [Related]
7. IGFBPrP1 accelerates autophagy and activation of hepatic stellate cells via mutual regulation between H19 and PI3K/AKT/mTOR pathway.
Huang TJ; Ren JJ; Zhang QQ; Kong YY; Zhang HY; Guo XH; Fan HQ; Liu LX
Biomed Pharmacother; 2019 Aug; 116():109034. PubMed ID: 31152924
[TBL] [Abstract][Full Text] [Related]
8. Carvacrol alleviates liver fibrosis by inhibiting TRPM7 and modulating the MAPK signaling pathway.
Cai S; Wu L; Yuan S; Liu G; Wang Y; Fang L; Xu D
Eur J Pharmacol; 2021 May; 898():173982. PubMed ID: 33647257
[TBL] [Abstract][Full Text] [Related]
9. LncRNA-H19 induces hepatic stellate cell activation via upregulating alcohol dehydrogenase III-mediated retinoic acid signals.
Wang ZM; Xia SW; Zhang T; Wang ZY; Yang X; Kai J; Cheng XD; Shao JJ; Tan SZ; Chen AP; Wang SJ; Zhang F; Zhang ZL; Zheng SZ
Int Immunopharmacol; 2020 Jul; 84():106470. PubMed ID: 32304991
[TBL] [Abstract][Full Text] [Related]
10. Role of growth factor receptor-bound 2 in CCl
Ge S; Xiong Y; Wu X; Xie J; Liu F; He J; Xiang T; Cheng N; Lai L; Zhong Y
Biomed Pharmacother; 2017 Aug; 92():942-951. PubMed ID: 28618656
[TBL] [Abstract][Full Text] [Related]
11. Sennoside A prevents liver fibrosis by binding DNMT1 and suppressing DNMT1-mediated PTEN hypermethylation in HSC activation and proliferation.
Zhu H; He C; Zhao H; Jiang W; Xu S; Li J; Ma T; Huang C
FASEB J; 2020 Nov; 34(11):14558-14571. PubMed ID: 32946656
[TBL] [Abstract][Full Text] [Related]
12. SOD3 deficiency induces liver fibrosis by promoting hepatic stellate cell activation and epithelial-mesenchymal transition.
Sun YL; Bai T; Zhou L; Zhu RT; Wang WJ; Liang RP; Li J; Zhang CX; Gou JJ
J Cell Physiol; 2021 Jun; 236(6):4313-4329. PubMed ID: 33230845
[TBL] [Abstract][Full Text] [Related]
13. Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo.
Du G; Wang J; Zhang T; Ding Q; Jia X; Zhao X; Dong J; Yang X; Lu S; Zhang C; Liu Z; Zeng Z; Safadi R; Qi R; Zhao X; Hong Z; Lu Y
Cell Death Dis; 2020 Feb; 11(2):118. PubMed ID: 32051399
[TBL] [Abstract][Full Text] [Related]
14. Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways.
Li J; Li X; Xu W; Wang S; Hu Z; Zhang Q; Deng X; Wang J; Zhang J; Guo C
Liver Int; 2015 Apr; 35(4):1222-33. PubMed ID: 25040634
[TBL] [Abstract][Full Text] [Related]
15. Repression of Smad7 mediated by DNMT1 determines hepatic stellate cell activation and liver fibrosis in rats.
Bian EB; Huang C; Wang H; Chen XX; Zhang L; Lv XW; Li J
Toxicol Lett; 2014 Jan; 224(2):175-85. PubMed ID: 24211420
[TBL] [Abstract][Full Text] [Related]
16. Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.
Shi Z; Ren M; Rockey DC
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G504-G517. PubMed ID: 31928221
[TBL] [Abstract][Full Text] [Related]
17. DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats.
Bian EB; Huang C; Ma TT; Tao H; Zhang H; Cheng C; Lv XW; Li J
Toxicol Appl Pharmacol; 2012 Oct; 264(1):13-22. PubMed ID: 22841775
[TBL] [Abstract][Full Text] [Related]
18. Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway.
Sui M; Jiang X; Chen J; Yang H; Zhu Y
Biomed Pharmacother; 2018 Oct; 106():125-133. PubMed ID: 29957462
[TBL] [Abstract][Full Text] [Related]
19. Fibrogenic Activity of MECP2 Is Regulated by Phosphorylation in Hepatic Stellate Cells.
Moran-Salvador E; Garcia-Macia M; Sivaharan A; Sabater L; Zaki MYW; Oakley F; Knox A; Page A; Luli S; Mann J; Mann DA
Gastroenterology; 2019 Nov; 157(5):1398-1412.e9. PubMed ID: 31352003
[TBL] [Abstract][Full Text] [Related]
20. Methylation of RCAN1.4 mediated by DNMT1 and DNMT3b enhances hepatic stellate cell activation and liver fibrogenesis through Calcineurin/NFAT3 signaling.
Pan XY; You HM; Wang L; Bi YH; Yang Y; Meng HW; Meng XM; Ma TT; Huang C; Li J
Theranostics; 2019; 9(15):4308-4323. PubMed ID: 31285763
[No Abstract] [Full Text] [Related]
[Next] [New Search]